Pharm - hepatitis and jaundice Flashcards

1
Q

What list of meds can cause drug induced liver injury

A

acetaminophen
anesthetics
NSAIDs
antimicrobials
antifungals
HIV antiretroviral therapy
oral hypoglycemics
lipid lowering agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is R value

A

ALT/ULN ALT
DIVIDED BY
ALP/ULN ALP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is hepatocellular R

A

R >= 5
more severe prognosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is mixed R

A

R = 2-5
More prone to chronic disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is cholestatic R

A

R <= 2
more prone to chronic disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What predicts prognosis with acetaminophen OD

A

Rumack-Matthew nomogram
Kings College criteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the initial management for acetaminophen OD

A

gastric emptying via lavage
activated charcoal within 4 hours ingestion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the specific antidote for acetaminophen OD

A

Mucomyst (N-acetyl-cysteine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What antimicrobials can cause drug induced hepatitis

A

beta lactams
beta lactamase inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What oral hypoglycemic is assoc with cholestatic injury pattern

A

Glimepiride

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What lipid lowering agents may cause drug induced hepatitis

A

statins
ezetimibe

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What differentiates acute viral hepatitis from chronic viral hepatitis?

A

greater or less than 6 months
A is only acute

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe hep A

A

acute, self-limited
person to person via fecal oral route or ingestion of contaminated food or water
assoc with poor sanitation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Hep A clinical presentation

A

incubation period 28 days
symptoms may or may not be present

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What labs indicated hep A

A

elevated aminotransferases
detection of IgM antibody to HAV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How to manage hep A

A

no treatment
supportive
avoid hepatotoxic substances

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How to prevent hep A

A

hand washing
Havrix and Vaqta vaccines
combo vax Twinrix (HAV and HBV)
Immunoglobulin dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

When to give Havrix

A

0, then 6-12 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

When to give VAQTA

A

0, then 6-18 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Who is recommended to get Hep A vax

A

all children older than 1
Increased infection risk
-MSM
-injection & non-injection drugs
-occupational risks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Postexposure prophylaxis for HAV

A

if vaxxed, nothing
no vax - vaccine or immunoglobulin as soon as possible within 2 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

When is immunoglobulin preferred for HAV postexposure prophylaxis rather than vax?

A

<12 months
Immunocompromised
Chronic liver disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is the same between Hep B and Hep C

A

transmitted by blood
targets liver
acute or chronic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is different between Hep B and Hep C

A

DNA vs RNA virus
vaccine with 3 injections vs no vax
treat with NRTIs vs NSSA inhibitor, protease inhibitor, polymerase inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What does HBsAg (surface antigen) tell you?

A

live active virus/active Hep infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What does HBeAG identify?

A

active replication of HBV

27
Q

What does Anti-HBc (core antigen) indicate?

A

active virus present or was present but cleared by the immune system

28
Q

What does IgM anti-HBs tell you?

A

acute phase of infection

29
Q

What does IgG anti-HBs tell you?

A

immunity from clearing infection or from immunization

30
Q

What will be positive if patient is immune to hep B due to infection and NOT the immunization?

31
Q

What is the only positive lab if patient is immune to HBV due to immunization?

32
Q

What classification is used for hepatitis B?

A

child turcotte pugh classification

33
Q

What is the common co-infection with HBV?

A

HIV or HCV

34
Q

What class and specific med is hep B treatment

A

Nucleoside analog class
NRTI - nucleoside reverse transcriptase inhibitors

35
Q

What are some treatment considerations for hep B treatment?

A
  1. After clearance treat another 6 months
  2. Renal dose (dose reductions)
  3. If treatment is stopped prematurely or abruptly severe acute worsening of liver function may occur
36
Q

What is interferon based therapy for Hep B

A

Peg-IFN-2a (pegasys) subQ

37
Q

What are adverse effects of Pegasys

A

fatigue
autoimmune disorders

38
Q

What patients are ineligible for Pegasys therapy

A

Baseline neutrophil count <1500
Platelet count <90,000
Hgb < 10

39
Q

What are nucleos(t)ide analogs for hep B treatment?

A

Adefovir
Entecavir
Lamivudine
Tenofovir (also for HIV)

40
Q

When should Adefovir not be used and why

A

HIV concomitant infection because if HIV untreated can cause resistance

41
Q

What is recommended for hep B prevention testing

A

HBsAG testing
immunization offered to all individuals testing seronegative

42
Q

Who is recommended to get Hep B vax

A

multiple sexual partners
MSM
IVDU
HIV + patients
End stage renal disease
Workers at high risk of occupational exposure

43
Q

What are the single antigen formations of HBV vax

A

Recombivax HB
Engerix-B

44
Q

What is a combination HBV vax

A

Twinrix (HBsAg and HAV)

45
Q

What vaccines for HBV for children?

A

comvax
pediarix

46
Q

When is serologic testing for immunity recommended?

A

advised in situations of known status indicating clinical management
-health care workers
-HIV infections
-immunosuppressed patients

47
Q

What determines the efficacy of postexposure prophylaxis?

A

how quickly the vaccine is administered
-within 7 days for needle stick
-within 14 days for sexual exposure

48
Q

What should be done for perinatal exposure

A

if born to a HBsAg + mother give HBV vaccine and HBIG within 12-24 hours after birth

49
Q

What should be given if exposed to source with HBsAg positive

A

completed vaccine series - give booster dose

50
Q

What should be given to unvaccinated individuals when exposed?

A

HBIG and begin vaccine series within 24 hours postexposure

51
Q

What are the risk exposures for Hep C that indicate screening/testing

A

hemodialysis - long term
Needle stick (health care workers)
Newborn of HCV + mother
M/M unprotected sex

52
Q

What is the goal of Anti-HCV therapy

A

Virologic cure
continuous absence of detectable HCV RNA at least 12 weeks after completion of therapy

53
Q

What are the clinical benefits of hep C treatment

A

reduced complication development
improved quality of life
reduce all-cause mortality

54
Q

What factor improves outcomes of Hep C treatment

A

early initiation

55
Q

What is common co infection with hep C

A

HIV or HBV

56
Q

What are the protease inhibitors used to treat Hep C

A

Grazoprevir
Paritaprevir
Ritonavir
Voxilaprevir
Glecaprevir

57
Q

MOA with protease inhibitors

A

inhibit cleavage of HCV-encoded polyprotein

58
Q

What are NS5B RNA polymerase inhibitors used to treat Hep C and MOA

A

Dasabuvir
Sofosbuvir

Inhibits NS5B RNA-dependent RNA polymerase activity

59
Q

What are the NS5A inhibitors used to treat Hep C and MOA

A

Daclatasvir
Elbasvir
Ledipasvir
Ombitasvir
Veltpatasvir
Pibrentasvir

Binds to the N-terminus on domain 1 of the HCV

60
Q

What to note about sofosbuvir+Velpatasvir (Epsula)

A

covers all genotypes (1-6)

61
Q

What to note about Glecaprevir + Pibrentasvir (Mavyret)

A

Covers all genotypes (1-6)
Protease + NS5A inhibitor

62
Q

What to note about Anti-HCV therapy concerns

A

Treating HCV can lead to reactivation of HBV
Important to obtain adequate history and screening!

63
Q

What is an Anti-HCV therapy

A

PEG-IFN-2 (Pegasys) + ribavirin

64
Q

Is there a vaccine for Hep C prevention